- Report
- May 2024
- 194 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- October 2023
- 128 Pages
Europe
From €4222EUR$4,400USD£3,651GBP
- Report
- January 2024
North America
From €1439EUR$1,500USD£1,245GBP
- Report
- March 2023
- 182 Pages
Global
From €1822EUR$1,899USD£1,576GBP
- Report
- August 2018
- 422 Pages
Global
From €4318EUR$4,500USD£3,734GBP
- Report
- June 2020
- 63 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- March 2024
- 150 Pages
From €4980EUR$5,190USD£4,306GBP
- Report
- September 2020
- 147 Pages
Asia Pacific
From €2015EUR$2,100USD£1,742GBP
€2878EUR$3,000USD£2,489GBP
- Report
- October 2023
- 99 Pages
Global
From €3500EUR$3,908USD£3,132GBP
- Report
- November 2021
- 747 Pages
Global
From €3838EUR$4,000USD£3,319GBP
- Book
- February 2023
- 576 Pages
- Book
- December 2022
- 464 Pages
- Book
- January 2013
- 632 Pages
The Drug Carrier market is a subset of the Drug Delivery industry, which focuses on the development and manufacture of products that transport drugs to their intended target. Drug Carriers are typically designed to protect the drug from degradation, increase its bioavailability, and reduce its toxicity. They can be composed of a variety of materials, including polymers, lipids, and proteins. Drug Carriers can also be used to modify the release rate of the drug, allowing for more controlled and sustained delivery.
Drug Carriers are used in a variety of drug delivery systems, including oral, topical, and injectable. They are also used in combination with other drug delivery technologies, such as nanotechnology and gene therapy.
Some companies in the Drug Carrier market include 3M, AbbVie, Amgen, AstraZeneca, Baxter, Becton Dickinson, CSL Behring, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
